No open-market selling at Lumexa Imaging Holdings, Inc. in the past year, which is unusual. Instead two company insiders bought into about $477,000 worth of LMRI.
The largest purchase came from BRODNAX BRETT (Director), about $254,000.
On the institutional side, 103 funds reported holding LMRI at the end of Q2 2026, and more funds bought than sold. No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | BRODNAX BRETT | Director | Buy | 35,000 | $7.25 | $254K | SEC |
| May 18, 2026 | Cooper Henry Lee | Director | Buy | 30,000 | $7.44 | $223K | SEC |
In the last 12 months Lumexa Imaging Holdings, Inc. insiders made open-market purchases worth about $477,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in LMRI was filed on 2026-05-21.
103 investment managers reported holding LMRI in SEC Form 13F filings for Q2 2026.
No congressional trades in LMRI were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).